JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

Jason Aynardi, Rashmi Manur, Paul R. Hess, Seble Chekol, Jennifer J.D. Morrissette, Daria Babushok, Elizabeth Hexner, Heesun J. Rogers, Eric D. Hsi, Elizabeth Margolskee, Attilio Orazi, Robert Hasserjian, Adam Bagg

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences